Nancy Yu

@nancyyu25

CEO of . Ex-23andme. Recovering biotech banker. My mission is to bring new science to the market.

San Francisco, CA
linkedin.com/in/yunancy
Vrijeme pridruživanja: travanj 2009.
8 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @nancyyu25

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @nancyyu25

  1. 16. pro 2019.

    So excited that Stephanie Fischer has joined us to accelerate treatments in rare disease at ! We’re so pumped to have you in on this mission. 💪🚀🙏👯‍♀️

    Excited to share that I've joined as Patient Advocacy & Partnerships Director! The company was founded by to accelerate drug development Love the quote on the homepage: "Patients shouldn’t be bystanders in drug development.”
    1 reply 6 proslijeđenih tweetova 50 korisnika označava da im se sviđa
    Poništi
  2. 12. stu 2019.

    The power of deep evidence in serves a big purpose: to ignite interest from drug researchers to actually take on a condition. Insights drive action.

    Together, we can power faster, better drug development for . With no speed limit on the German “autobahn,” we’d say that means pretty fast! But we need your help to make that happen. Will you RT to help us spread the movement? Join us:
    2 proslijeđena tweeta 12 korisnika označava da im se sviđa
    Poništi
  3. 2. stu 2019.

    🚀 this team is 7,000 kinds of awesome

    Sometimes I wonder how I ended up working in and . Then, I look around our office and see these people. This is where I want to be, where everyone truly cares; everyone is mission-driven, relentless, and grounded. So proud of this team
    7 korisnika označava da im se sviđa
    Poništi
  4. 31. lis 2019.

    Woo! Go

    A commentary on our work from on attitudes & understanding of clinical research in Huntington’s disease was recently released; honored to be highlighted with my coauthors!
    Prikaži ovu nit
    1 korisnik označava da mu se sviđa
    Poništi
  5. 4. lis 2019.

    It’s not enough to be fighting rare disease by day - is a volunteer at Shanti Project by night (in the little spare time she has)! I remember when we found Charlene she was about to travel the world for a year. She put that on hold to join the mission! 🙏

    “Because of your efforts we exist, because of your efforts we continue to exist” - Dr. Charlie Garfield so honored to be a peer support volunteer at Shanti Project
    1 reply 8 korisnika označava da im se sviđa
    Poništi
  6. 3. lis 2019.

    Yes.

    Patrick Ryan of Janssen and : When is reliable, we should NOT expect it to tell the same story as .
    Poništi
  7. 3. lis 2019.

    “Data standards are like toothbrushes - everyone has one, and nobody wants to use anyone else’s.” 😂

    5 proslijeđenih tweetova 35 korisnika označava da im se sviđa
    Poništi
  8. 3. lis 2019.

    Live tweeting from the National Press Club in DC! This is going to be an awesome discussion on using Real World Evidence to support regulatory decision making in drug development. Live webcast details below:

    2 proslijeđena tweeta 14 korisnika označava da im se sviđa
    Poništi
  9. 2. lis 2019.

    Excited to be featured in the top 150 most promising digital health companies - advancing drug development in !

    1 reply 2 proslijeđena tweeta 11 korisnika označava da im se sviđa
    Poništi
  10. 30. ruj 2019.

    The holdouts closing down the bar... at . Had a blast - thanks for coming!!

    Can’t believe that was just last week!
    13 korisnika označava da im se sviđa
    Poništi
  11. 19. ruj 2019.

    The more patient stories we tell, the more research we influence.

    2 proslijeđena tweeta 13 korisnika označava da im se sviđa
    Poništi
  12. 13. ruj 2019.

    👏

    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  13. 13. ruj 2019.

    This is why we need to build a model specific to rare disease, not adapt the traditional R&D model from common diseases: All diseases will eventually be rare diseases.

    1 reply 2 proslijeđena tweeta 16 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  14. 6. ruj 2019.

    Let’s talk Real World Evidence in rare neurological diseases!

    Technology & Rare Neurological Diseases Symposium (TRNDS) 2019, University of Rochester, CDER FDA, RDMD, MC10, Blackfynn, URMC, #RareDisease, #TRNDS2019, #TRNDS
    Don't miss this Panel: Real World Evidence Moderated by Karl Kieburtz () with (), Ben Schlatka (), (), Dina Zand (CDER/) Agenda Register
    2 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Poništi
  15. 4. ruj 2019.

    This is why we get so much done at

    16 korisnika označava da im se sviđa
    Poništi
  16. 3. ruj 2019.

    Today my mom asked me if for a startup involved me treating VCs to bountiful lunches and dinners and keeping them entertained. 🤔 I must be doing this all wrong.

    1 reply 8 korisnika označava da im se sviđa
    Poništi
  17. 30. kol 2019.

    Every year, we fly out our entire team to because it’s one of the best opportunities to meet with all the warriors out there. 👊💪So excited to catch up with everyone soon!

    Only 3 more weeks until ! Excited to meet so many amazing people committed to !
    2 proslijeđena tweeta 11 korisnika označava da im se sviđa
    Poništi
  18. 22. kol 2019.

    How comes up with new ideas 😂

    1 reply 8 korisnika označava da im se sviđa
    Poništi
  19. 20. kol 2019.

    Just re-watered half my plants when they didn’t need watering because I had my moisture meter set on “ph” and not “moisture level.” The dangers of relying too much on tech and not common sense...🙄

    5 korisnika označava da im se sviđa
    Poništi
  20. 20. kol 2019.

    isn’t a science problem. The problem is there’s no easy way for researchers to deeply characterize the disease itself (). How can researchers and FDA design successful trials when this information is trapped in hospitals or just doesn’t exist?

    1 reply 2 proslijeđena tweeta 12 korisnika označava da im se sviđa
    Poništi

@nancyyu25 još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·